• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues.

作者信息

Lokeshwar B L, Selzer M G, Block N L, Gunja-Smith Z

机构信息

Department of Urology, University of Miami School of Medicine, Florida 33101.

出版信息

Cancer Res. 1993 Oct 1;53(19):4493-8.

PMID:7691397
Abstract

Unregulated secretion of matrix metalloproteinases (MMPs) or their endogenous protein inhibitors (tissue inhibitor of metalloproteinases, TIMPs) has been implicated in tumor invasion and metastasis. Species of MMPs and TIMPs secreted by epithelial cultures of normal, benign, and malignant prostate were identified and their levels were compared. Fragments of fresh tissue were cultured in a serum-free medium that supported the outgrowth of prostatic epithelial cells. Biochemical analysis of the conditioned media by gelatin zymography and enzyme assays showed that both normal and neoplastic tissues secreted latent and active forms of both M(r) 72,000 type IV collagenase (MMP-2) and M(r) 92,000 gelatinase (MMP-9). However, conditioned media from malignant prostate explants contained a higher proportion of the active form of MMP-2. Significant amounts of free TIMPs were secreted by normal juvenile and adult prostates, but they were either markedly reduced or not detectable in conditioned media from neoplastic tissues. These findings suggest that there is an imbalance of secretion between MMPs and TIMPs in prostatic carcinoma.

摘要

相似文献

1
Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues.
Cancer Res. 1993 Oct 1;53(19):4493-8.
2
Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in the retinal pigment epithelium and interphotoreceptor matrix: vectorial secretion and regulation.视网膜色素上皮和光感受器间基质中的基质金属蛋白酶-2和金属蛋白酶组织抑制剂-1:向量分泌与调节
Exp Eye Res. 1997 Jun;64(6):927-38. doi: 10.1006/exer.1997.0287.
3
Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.基质金属蛋白酶-2和-9及其抑制剂金属蛋白酶组织抑制剂-1和-2在人前列腺基质细胞和上皮细胞原代培养物中的表达
J Cell Physiol. 2002 May;191(2):208-16. doi: 10.1002/jcp.10092.
4
Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer.前列腺癌中金属蛋白酶的定量免疫组织化学和原位杂交分析
Anticancer Res. 2006 Mar-Apr;26(2A):973-82.
5
Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer.前列腺癌中的IV型胶原酶(基质金属蛋白酶-2和-9)
Prostate Cancer Prostatic Dis. 2004;7(4):327-32. doi: 10.1038/sj.pcan.4500750.
6
mRNA expression of the five membrane-type matrix metalloproteinases MT1-MT5 in human prostatic cell lines and their down-regulation in human malignant prostatic tissue.人前列腺细胞系中五种膜型基质金属蛋白酶MT1 - MT5的mRNA表达及其在人恶性前列腺组织中的下调
Prostate. 2003 May 1;55(2):89-98. doi: 10.1002/pros.10194.
7
Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate.基质金属蛋白酶-7和金属蛋白酶组织抑制剂-1在人前列腺中的表达
J Urol. 1998 Nov;160(5):1872-6.
8
mRNA expression profile of matrix metalloproteinases and their tissue inhibitors in malignant and non-malignant prostatic tissue.基质金属蛋白酶及其组织抑制剂在恶性和非恶性前列腺组织中的mRNA表达谱
Anticancer Res. 2003 May-Jun;23(3B):2617-24.
9
Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia.人前列腺中膜型1基质金属蛋白酶(MT1-MMP)和MMP-2的免疫定位:与高级别前列腺上皮内瘤变相关的细胞定位变化
Clin Cancer Res. 1999 Dec;5(12):4105-10.
10
Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion.基质金属蛋白酶9(明胶酶B)在人骨巨细胞瘤的多核巨细胞中表达,并与血管侵袭相关。
Am J Pathol. 1996 Feb;148(2):611-22.

引用本文的文献

1
The Role of the Metzincin Superfamily in Prostate Cancer Progression: A Systematic-Like Review.金属蛋白酶超家族在前列腺癌进展中的作用:一项类似系统综述
Int J Mol Sci. 2021 Mar 30;22(7):3608. doi: 10.3390/ijms22073608.
2
The Role of Extracellular Proteases in Tumor Progression and the Development of Innovative Metal Ion Chelators that Inhibit their Activity.细胞外蛋白酶在肿瘤进展中的作用和开发抑制其活性的创新金属离子螯合剂。
Int J Mol Sci. 2020 Sep 16;21(18):6805. doi: 10.3390/ijms21186805.
3
Semen levels of matrix metalloproteinase (MMP) and tissue inhibitor of metallorproteinases (TIMP) protein families members in men with high and low sperm DNA fragmentation.
高和低精子 DNA 碎片化男性的基质金属蛋白酶 (MMP) 和组织金属蛋白酶抑制剂 (TIMP) 蛋白家族成员的精液水平。
Sci Rep. 2019 Jan 29;9(1):903. doi: 10.1038/s41598-018-37122-4.
4
miR-618: possible control over TIMP-1 and its expression in localized prostate cancer.miR-618:局部前列腺癌中 TIMP-1 及其表达的可能调控。
BMC Cancer. 2018 Oct 19;18(1):992. doi: 10.1186/s12885-018-4930-4.
5
Tissue-based molecular markers in upper tract urothelial carcinoma and their prognostic implications.上尿路尿路上皮癌的组织分子标志物及其预后意义。
Int Braz J Urol. 2018 Jan-Feb;44(1):22-37. doi: 10.1590/S1677-5538.IBJU.2017.0204.
6
Metallothinein 1E Enhances Glioma Invasion through Modulation Matrix Metalloproteinases-2 and 9 in U87MG Mouse Brain Tumor Model.金属硫蛋白1E通过调节基质金属蛋白酶-2和9增强U87MG小鼠脑肿瘤模型中的胶质瘤侵袭。
J Korean Neurosurg Soc. 2016 Nov;59(6):551-558. doi: 10.3340/jkns.2016.59.6.551. Epub 2016 Oct 24.
7
TIMP-1 activated carcinoma-associated fibroblasts inhibit tumor apoptosis by activating SDF1/CXCR4 signaling in hepatocellular carcinoma.TIMP-1激活的癌相关成纤维细胞通过激活肝细胞癌中的SDF1/CXCR4信号传导来抑制肿瘤细胞凋亡。
Oncotarget. 2015 May 20;6(14):12061-79. doi: 10.18632/oncotarget.3616.
8
Immunohistochemical expression of matrix metalloproteinase-9 and inhibitor of matrix metalloproteinase-1 in prostate adenocarcinoma.基质金属蛋白酶-9和基质金属蛋白酶-1抑制剂在前列腺腺癌中的免疫组化表达
Int J Clin Exp Pathol. 2014 Dec 1;7(12):9090-8. eCollection 2014.
9
Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression.基质金属蛋白酶及其天然抑制剂在前列腺癌进展中的作用。
Cancers (Basel). 2014 Jun 27;6(3):1298-327. doi: 10.3390/cancers6031298.
10
A novel role for raloxifene nanomicelles in management of castrate resistant prostate cancer.雷洛昔芬纳米胶束在去势抵抗性前列腺癌治疗中的新作用。
Biomed Res Int. 2014;2014:323594. doi: 10.1155/2014/323594. Epub 2014 Feb 6.